mtor

Documents about mtor

• Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology.#275382NCBI PubMed Central
• A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer#1437410ClinicalTrials.gov
• Rapalog Pharmacology (RAP PAC) Study#1419421ClinicalTrials.gov
• Ventricular mTOR Inhibition to Prevent Hydrocephalus After Brain Hemorrhage#899707ClinicalTrials.gov
• mTOR as Mediator of Insulin Sensitivity Study#1281896ClinicalTrials.gov
• AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1#7053OpenAlex
• Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling#1072014ClinicalTrials.gov
• Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology#273312Europe PMC
• Leucine, mTOR and Athero#838398ClinicalTrials.gov
• mTOR and Adipose Tissue Inflammation#1140760ClinicalTrials.gov
• Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients#898282ClinicalTrials.gov
• Phytochemicals targeting PI3K/Akt/mTOR signaling pathway to treat rheumatoid arthritis#672216Recep Tayyip Erdoğan University Institutional Repository
• Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer#1320071ClinicalTrials.gov
• Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer#857338ClinicalTrials.gov
• Agmatine suppresses glycolysis via the PI3K/Akt/mTOR/HIF-1α signaling pathway and improves mitochondrial function in microglia exposed to lipopolysaccharide#448732IBISS
• Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mTOR Pathway in Gastric Carcinoma#948039Repositorio de Universidad Autónoma de Chile.
• MAZ-p53-mtor axis dysregulation drives hyperproliferation in autism 16pdel11.2 neural progenitor cells#212153RUcore, Rutgers University Community Repository
• Occurrence of Biased mTOR Signaling in Hepatocellular Carcinoma#481603bioRxiv / medRxiv
• mTOR disrupts cerebrovascular RNA regulatory networks in Alzheimers disease#1349070bioRxiv / medRxiv
• Formal Modeling of mTOR Associated Biological Regulatory Network Reveals Novel Therapeutic Strategy for the Treatment of Cancer#1000749HAL (France)
• The mTOR-Dop1a-Agpat2 axis regulates nuclear phospholipid homeostasis.#209469NCBI PubMed Central
• mTOR signalling pathway as a key-modulator in placenta development: cell functionality and gene expression of trophoblast adaptive response during the early stage of pregnancy in sheep#644342IRIS
• Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma#1094180ClinicalTrials.gov
• Regulation of eIF-4E BP1 Phosphorylation by mTOR#643604Harvard DASH
• mTOR signaling networks: mechanistic insights and translational frontiers in disease therapeutics#1390531HAL (France)
• Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of Alzheimer's disease#935794Repositorio de Universidad Autónoma de Chile.
• Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer#1498067ClinicalTrials.gov
• Novel 5-HT6R modulators as mTOR-dependent neuronal autophagy inductors#336269Repositorio USS
• Everolimus Aging Study#907967ClinicalTrials.gov
• Complete response to mTOR inhibitor following JAKi failure in severe pulmonary sarcoidosis#1235366HAL (France)
• The role of mechanistic target of rapamycin (mTOR) signalling in skeletal muscle ageing#474207University of Nottingham Repository
• Nuclear mTOR-Polycomb synergism at developmental gene promoters prone to activation#243488bioRxiv / medRxiv
• Single-cell discovery of mTOR-associated microglial clusters in human mTORopathies#445485Europe PMC
• Study of Sirolimus in IgG4-related Disease#888151ClinicalTrials.gov
• Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia#1203437HAL (France)
• Pharmacokinetics of Calcineurin & mTOR Inhibitors in HIV-1 Infected Kidney Transplant Recipients After Switch to BIC/FTC/TAF#1465364ClinicalTrials.gov
• Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma#934600Koc University Digital Collections
• Sapu003 in Advanced mTOR-sensitive Solid Tumors#1454130ClinicalTrials.gov
• RRP9 suppresses hepatocellular carcinoma progression by inhibiting the PI3K/AKT/mTOR pathway.#143212NCBI PubMed Central
• mTOR regulates longevity through a bile-acid like hormonal mechanism and DHS- 26/DHRS1#279367bioRxiv / medRxiv
• Mosaic human cortical organoids model mTOR-related focal cortical dysplasia through \textitDEPDC5 deletion#360068HAL (France)
• Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis#813672ClinicalTrials.gov
• An mTOR feedback loop mediates the ‘flare’ (‘rebound’) response to MET tyrosine kinase inhibition#1146487HAL (France)
• Complete response to mTOR inhibitor following JAKi failure in severe pulmonary sarcoidosis: Authors’ reply#1235367HAL (France)
• A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)#827663ClinicalTrials.gov
• Stromal Cell–Derived Factor 1α Mediates Resistance to mTOR-Directed Therapy in Pancreatic Cancer#187185Zenodo (CERN)
• Everolimus for Cancer With TSC1 or TSC2 Mutation#873442ClinicalTrials.gov
• Assessment of the Safety, Tolerability and Pharmacokinetics of AV078 in Healthy Volunteers#1100431ClinicalTrials.gov
• Inhibition of FKBP51 alleviates depressive-like behaviors via AKT/mTOR-dependent autophagy and synaptic plasticity.#242127NCBI PubMed Central
• Characterization of TRIB2-mTORC1 signaling in melanoma#651674eScholarship